Modeling laboratory data from clinical trials

被引:5
|
作者
Rosenkranz, Gerd K. [1 ]
机构
[1] Novartis Pharma AG, CH-4056 Basel, Switzerland
关键词
D O I
10.1016/j.csda.2008.07.005
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Abnormal laboratory data from clinical trials are considered precursors of potential organ dysfunction. Routine analysis of these data focusses primarily on the incidence of extremely high or low values relative to normal ranges, or the change of these incidences compared to baseline. Alternatively, the worst values from each individual patient are analyzed. Where feasible, graphical representations of the time course of lab measurements are displayed, often for each subject individually. However, only rarely is an attempt made to model the dynamics of the measurements over time. Stochastic processes can be used to model laboratory measurements and specifically Ornstein-Uhlenbeck processes have some properties that are suitable for this purpose. Models based on these processes can account for potential systematic effects relevant for all or a group of subjects as well as the random variation between subjects. The idea is to estimate parameters of these processes in order to quantify effects of drugs or other medical treatments. Results based on simulations and real data will be presented. (C) 2008 Elsevier B. V. All rights reserved.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [1] Laboratory controlled trials are different from clinical trials
    Betts, James A.
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [2] The clinical data interchange standards consortium laboratory model: Standardizing laboratory data interchange in clinical trials
    Bassion, S
    DRUG INFORMATION JOURNAL, 2003, 37 (03): : 271 - 281
  • [3] The Clinical Data Interchange Standards Consortium Laboratory Model: Standardizing Laboratory Data Interchange in Clinical Trials
    Susan Bassion
    Drug information journal : DIJ / Drug Information Association, 2003, 37 : 271 - 281
  • [4] Toward a laboratory data interchange standard for clinical trials
    Bassion, S
    CLINICAL CHEMISTRY, 2002, 48 (12) : 2290 - 2292
  • [5] Laboratory data in clinical trials: A statistician's perspective
    Chuang-Stein, C
    CONTROLLED CLINICAL TRIALS, 1998, 19 (02): : 167 - 177
  • [6] Data systems for clinical trials and basic sciend laboratory research data
    Anderson, L
    Pense, R
    Moffitt, HL
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2000, : 953 - 953
  • [7] BRAF inhibitors: From the laboratory to clinical trials
    Rahman, M. A.
    Salajegheh, A.
    Smith, R. A.
    Lam, A. K. -Y.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (03) : 220 - 232
  • [8] Harmonization of laboratory results by data adjustment in multicenter clinical trials
    Lee, Sang Gon
    Chung, Hee-Jung
    Park, Jeong Bae
    Park, Hyosoon
    Lee, Eun Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (06): : 1119 - +
  • [10] MODELING HIGH RESOLUTION DRINKING DATA IN CLINICAL TRIALS
    DeSantis, S. M.
    Bandyopadhyay, D.
    Baker, N. L.
    Randall, P. K.
    Prisciandaro, J. J.
    Anton, R. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 : 132A - 132A